Marchiafava–Bignami disease (MBD) is a rare neurological disorder characterized by degeneration and necrosis of the corpus callosum—the thick band of nerve fibers that connects the two cerebral hemispheres. First described in Italian wine drinkers in the early 20th century, MBD most commonly affects middle-aged men with a history of chronic, heavy alcohol consumption and poor nutrition. The hallmark of the disease is demyelination (loss of the myelin sheath around nerve fibers) and hemorrhagic necrosis (bleeding into dying tissue) of callosal fibers, often extending into adjacent white matter. Patients present with a spectrum of neuropsychiatric and motor symptoms, ranging from confusion and impaired consciousness to seizures and severe motor deficits. Magnetic resonance imaging (MRI) typically reveals symmetric lesions in the corpus callosum, while diffusion‐weighted imaging may demonstrate restricted diffusion in acute stages. Without prompt recognition and management—primarily nutritional support and thiamine supplementation—MBD can progress to coma or death.
Marchiafava–Bignami Disease (MBD) is a rare neurological disorder characterized by progressive demyelination and necrosis of the corpus callosum, the bundle of nerve fibers that connects the two cerebral hemispheres. First described in 1903 by Ettore Marchiafava and Amico Bignami in chronic alcoholics, MBD most commonly affects middle-aged men with a long history of heavy ethanol consumption. The typical presentation includes confusion, lethargy, dysarthria, gait disturbances, seizures, and in severe cases, coma or death. Magnetic resonance imaging (MRI) reveals symmetric lesions in the corpus callosum, often extending to adjacent white matter.
Types of Marchiafava–Bignami Disease
Acute MBD
In the acute form, patients develop rapid-onset symptoms over hours to days, including sudden confusion, dysarthria (slurred speech), and altered consciousness. Neuroimaging often shows prominent callosal edema, hemorrhage, and diffusion restriction. If untreated, acute MBD can lead to deep coma and carries a high mortality rate.Subacute MBD
Subacute presentations unfold over days to weeks. Patients experience fluctuating mental status changes, gait disturbances, and mild memory impairment. MRI findings may combine features of acute edema with early signs of chronic demyelination. With timely thiamine therapy and nutritional rehabilitation, many patients partially recover.Chronic MBD
Chronic MBD evolves over weeks to months and is typified by the gradual emergence of interhemispheric disconnection syndromes—impaired coordination between the left and right sides of the body—along with persistent cognitive impairment. Neuroimaging reveals thinning and atrophy of the corpus callosum, and recovery is often incomplete, with lasting deficits in executive function and motor skills.
Causes
Chronic Alcoholism
The most common predisposing factor, chronic heavy drinking induces direct neurotoxicity, poor nutritional intake, and thiamine deficiency, all of which contribute to callosal degeneration.Thiamine (Vitamin B₁) Deficiency
Thiamine is crucial for neuronal energy metabolism. Deficiency impairs ATP production, leading to selective vulnerability of callosal fibers.Malnutrition
Inadequate intake of essential nutrients, especially B vitamins, exacerbates neuronal vulnerability and demyelination.Liver Disease
Chronic liver failure impairs detoxification and leads to hyperammonemia, which can damage central nervous system structures, including the corpus callosum.Hypoglycemia
Severe drops in blood glucose deprive neurons of energy, potentially causing focal necrosis in susceptible white matter tracts.Electrolyte Imbalance
Hyponatremia or hypomagnesemia can precipitate osmotic and metabolic stress in neural tissue, contributing to MBD pathology.Hepatic Encephalopathy
Toxin accumulation in liver failure can disrupt neurotransmission and integrity of interhemispheric fibers.Sepsis
Systemic infection with inflammatory cytokine release can compromise the blood–brain barrier and promote white matter injury.Wernicke’s Encephalopathy
Often coexists with Wernicke’s, sharing thiamine deficiency as a root cause; affected patients may transition from Wernicke’s to MBD.Postoperative States
Following major surgery, malnutrition and metabolic derangements may unmask subclinical MBD.Chemotherapy
Certain chemotherapeutic agents (e.g., ifosfamide) can induce leukoencephalopathy and predispose to callosal damage.Epileptic Status
Prolonged seizures lead to metabolic exhaustion in neurons and glia, potentially damaging the corpus callosum.Hypoxia
Reduced oxygen delivery in cardiac or respiratory failure can especially affect watershed areas like the corpus callosum.Radiation Therapy
Cranial irradiation may cause delayed white matter necrosis, including in the corpus callosum.HIV Infection
Viral neurotoxicity and opportunistic infections can target white matter tracts.Autoimmune Disorders
Conditions like systemic lupus erythematosus may induce demyelination via inflammatory mechanisms.Metabolic Disorders
Rare inborn errors of metabolism (e.g., maple syrup urine disease) can lead to toxic accumulations affecting white matter.Neurosyphilis
Tertiary syphilis can cause gummatous lesions and demyelination in cerebral structures.Creutzfeldt–Jakob Disease
Rapidly progressive prion disease may involve callosal spongiform changes.Paraneoplastic Syndromes
Remote effects of malignancies can trigger immune-mediated white matter injury.
Symptoms
Confusion
Patients often present with acute disorientation, inability to recognize surroundings, and difficulty following conversations.Altered Consciousness
Ranging from drowsiness to stupor and deep coma, reflecting the extent of callosal involvement.Dysarthria
Slurred, slow, or uneven speech arises from impaired interhemispheric coordination of motor speech areas.Gait Ataxia
Unsteady, wide-based gait due to disrupted communication between hemispheres controlling posture and balance.Weakness
Often bilateral and symmetric, reflecting diffuse callosal fiber impairment.Intermanual Conflict
The “alien hand” phenomenon: one hand acts involuntarily, demonstrating split-brain effects.Cranial Nerve Palsies
Less common, but may indicate extension of necrosis beyond the corpus callosum.Seizures
Focal or generalized seizures occur in up to half of cases during the acute phase.Psychosis
Auditory or visual hallucinations and delusional thinking may develop, particularly in chronic MBD.Memory Loss
Both short-term and declarative memory impairment, reflecting involvement of frontal–limbic pathways.Emotional Lability
Rapid mood swings, irritability, or inappropriate emotional expression due to frontal lobe disconnection.Headache
Often dull and diffuse, secondary to inflammation and edema.Nausea and Vomiting
Common in acute presentations with raised intracranial pressure.Visual Disturbances
Blurred vision or visual field defects from involvement of occipital callosal fibers.Nystagmus
Involuntary eye movements reflecting brainstem or cerebellar extension.Sensory Loss
Paresthesia or hypoesthesia, usually bilateral, due to white matter tract disruption.Hyperreflexia
Exaggerated deep tendon reflexes, particularly in the lower limbs.Positive Babinski Sign
Indicative of upper motor neuron involvement.Fatigue
Severe, disproportionate tiredness stemming from diffuse cerebral dysfunction.Apraxia
Inability to perform learned movements, despite intact motor strength, due to interhemispheric disconnection.
Diagnostic Tests
A. Physical Examination
Mental Status Exam
Assessment of orientation, attention, and cognition to gauge severity of encephalopathy.Cranial Nerve Assessment
Evaluates ocular motility, facial symmetry, and swallowing.Motor Power Testing
Grading muscle strength (0–5) to detect hemiparesis or quadriparesis.Deep Tendon Reflexes
Hyperreflexia suggests upper-motor-neuron involvement.Muscle Tone Assessment
Identifies spasticity or rigidity.Gait Analysis
Observation for ataxic or spastic gait patterns.Coordination Tests
Finger-nose and heel-shin tests reveal cerebellar dysfunction.Sensory Examination
Light touch, pain, and vibration senses to rule out peripheral neuropathy.
B. Manual (Disconnection) Tests
Intermanual Conflict Test
One hand opposes the actions of the other, indicating callosal disconnection.Crossed‐Hand Naming Task
Examines ability to name objects placed in the non-dominant hand.Tactile Naming Test
Assess naming of objects felt but not seen, probing interhemispheric transfer.Graphesthesia Test
Writing on one palm; difficulty indicates sensory callosal involvement.Dichotic Listening Task
Assesses auditory interhemispheric transfer using competing sounds.Rey–Osterrieth Figure Copy
Complex figure copying tests visuospatial integration.Lexical Decision Test
Word recognition tasks that challenge hemispheric cooperation.Gesture Imitation
Evaluates praxis and motor planning across hemispheres.
C. Laboratory and Pathological Tests
Complete Blood Count (CBC)
Rules out infection or anemia contributing to encephalopathy.Serum Electrolytes
Detects hyponatremia, hypokalemia, or other imbalances affecting the CNS.Liver Function Tests (LFTs)
Assesses hepatic dysfunction from alcohol abuse.Serum Thiamine Level
Confirms B₁ deficiency, a key etiological factor.Vitamin B₁₂ and Folate Levels
Rules out other nutritional causes of white-matter disease.Blood Glucose
Excludes hypoglycemia as a confounder.Ammonia Level
Elevated in hepatic encephalopathy, requiring differentiation.CSF Analysis
Cell count, protein, glucose; typically normal in MBD but helps exclude infection.
D. Electrodiagnostic Tests
Electroencephalogram (EEG)
Detects diffuse slowing or epileptiform discharges in acute MBD.Somatosensory Evoked Potentials (SSEPs)
Evaluates conduction through central sensory pathways.Visual Evoked Potentials (VEPs)
Assesses optic tract involvement if visual symptoms present.Brainstem Auditory Evoked Potentials (BAEPs)
Screens for brainstem dysfunction in severe cases.Nerve Conduction Studies (NCS)
Rules out peripheral neuropathy mimicking certain symptoms.Magnetoencephalography (MEG)
Experimental; maps interhemispheric transfer delays.Transcranial Magnetic Stimulation (TMS)
Assesses motor-evoked potentials across hemispheres.Electromyography (EMG)
Differentiates central versus peripheral motor deficits.
E. Imaging Tests
Magnetic Resonance Imaging (MRI)
Gold standard: T1‐, T2‐, and FLAIR sequences show corpus callosum lesions.Diffusion-Weighted Imaging (DWI)
Identifies acute cytotoxic edema within callosal fibers.Apparent Diffusion Coefficient (ADC) Maps
Differentiates acute (restricted diffusion) from chronic (facilitated diffusion) changes.Magnetic Resonance Spectroscopy (MRS)
Reveals decreased N-acetylaspartate and elevated choline in affected regions.Diffusion Tensor Imaging (DTI)
Quantifies fractional anisotropy reduction in callosal tracts.Computed Tomography (CT)
May show hypodense lesions but less sensitive than MRI.Contrast-Enhanced MRI
Excludes neoplastic or inflammatory mimics by assessing blood–brain barrier integrity.Functional MRI (fMRI)
Research tool to evaluate interhemispheric connectivity during tasks.
Non-Pharmacological Treatments
A. Physiotherapy and Electrotherapy Therapies
Balance Retraining
A structured program using wobble boards and parallel bars to improve proprioception and reduce fall risk by reinforcing compensatory pathways around damaged callosal tracts.Gait Training
Treadmill-based walking with harness support promotes neuroplasticity and motor relearning, enhancing interhemispheric coordination.Task-Specific Repetitive Exercises
Activities like sit-to-stand or stair climbing, repeated under therapist supervision, drive use-dependent cortical reorganization.Functional Electrical Stimulation (FES)
Low-intensity electrical pulses applied to lower limb muscles improve muscle strength and timing, aiding gait symmetry.Transcranial Direct Current Stimulation (tDCS)
Noninvasive electrical current over motor cortex regions may enhance cortical excitability and speed rehabilitation gains.Mirror Therapy
Patients perform movements of the unaffected limb while watching its mirror image, tricking the brain into activating bilateral networks.Robot-Assisted Therapy
Devices like Lokomat guide patient’s limbs through normal gait patterns, promoting high-repetition, low-fatigue training.Upper-Limb Constraint-Induced Movement Therapy (CIMT)
Restricting the unaffected arm forces use of the affected side, driving motor recovery.Vestibular Rehabilitation
Gaze stabilization and habituation exercises address balance deficits secondary to callosal disconnection.Proprioceptive Neuromuscular Facilitation (PNF)
Diagonal movement patterns with manual resistance facilitate coordination across affected neural pathways.Hydrotherapy
Aquatic walking and balance drills reduce weight-bearing stress, allowing safe movement training.Spasticity Management with Neuromuscular Taping
Elastic tape applied along muscle fibers normalizes tone and improves joint alignment.Biofeedback-Assisted Therapy
Real-time EMG or force-plate feedback helps patients adjust movement patterns and muscle activation.Sensory Re-education
Tactile discrimination and vibration stimulation enhance sensory integration and hand dexterity.Cardiovascular Endurance Training
Cycle ergometry or recumbent stepping supports overall brain perfusion and general health.
B. Exercise Therapies
Aerobic Interval Training
Short bursts of moderate-intensity exercise interspersed with rest periods boost cerebral blood flow and neurotrophic factor release.Resistance Band Strengthening
Progressive loading of major muscle groups enhances motor control and counteracts disuse atrophy.Tai Chi
Slow, flowing movements improve balance, attention, and interhemispheric communication.Yoga
Combined stretching, breath control, and meditation reduce stress and support neural repair.Pilates
Core-stabilizing exercises foster postural control and coordination.
C. Mind-Body Therapies
Mindfulness Meditation
Training in nonjudgmental awareness of thoughts and sensations reduces anxiety and may enhance neural plasticity.Guided Imagery
Visualization of movement sequences activates mirror neuron systems and primes motor pathways.Music Therapy
Rhythmic auditory stimulation entrains walking cadence and encourages bilateral brain activation.Art Therapy
Creative expression engages cognitive and motor skills, promoting adaptive coping.Biofeedback Meditation
Combining heart-rate variability feedback with relaxation strengthens autonomic regulation.
D. Educational Self-Management
Disease Education Workshops
Teaching patients and caregivers about MBD pathophysiology empowers informed decision-making.Home Exercise Programs
Customized handouts and video tutorials reinforce clinic-based therapies.Fall Prevention Counseling
Identifying home hazards and strategizing safe ambulation reduces accidents.Nutrition and Hydration Guidance
Educating on balanced meals and alcohol avoidance supports neural healing.Assistive Technology Training
Instruction in using adaptive devices (e.g., walkers, canes, voice-activated systems) enhances independence.
Evidence-Based Drug Treatments
For MBD, pharmacotherapy focuses on correcting nutritional deficiencies, neuroprotection, and symptom control:
Thiamine (Vitamin B₁) – 500 mg IV daily for 3 days, then 100 mg IM daily
Class: Vitamin supplement
Purpose: Reverses Wernicke-like encephalopathy component
Side Effects: Rare allergic reactions, mild hypotensionFolate (Vitamin B₉) – 1 mg PO daily
Class: Vitamin supplement
Purpose: Supports DNA repair in demyelinated fibers
Side Effects: Gastrointestinal upsetMultivitamin Complex (B₆, B₁₂) – Daily oral dose per label
Class: Supplement
Purpose: Synergistic neurotrophic support
Side Effects: MinimalHigh-dose Corticosteroids (Methylprednisolone 1 g IV × 5 days)
Class: Anti-inflammatory
Purpose: Reduces cerebral edema and inflammation
Side Effects: Hyperglycemia, infection riskN-Acetylcysteine – 600 mg PO TID
Class: Antioxidant
Purpose: Scavenges free radicals, promotes glutathione synthesis
Side Effects: Nausea, rashAmantadine – 100 mg PO BID
Class: Dopaminergic agent
Purpose: Enhances arousal and cognitive function
Side Effects: Insomnia, peripheral edemaBromocriptine – 2.5 mg PO BID
Class: Dopamine agonist
Purpose: Improves motor initiation in callosal dysfunction
Side Effects: Orthostatic hypotension, nauseaMemantine – 5 mg PO daily, titrate to 10 mg BID
Class: NMDA receptor antagonist
Purpose: Neuroprotection against excitotoxicity
Side Effects: Dizziness, headacheGabapentin – 300 mg PO TID
Class: Anticonvulsant
Purpose: Manages neuropathic pain, spasticity
Side Effects: Somnolence, dizzinessLevetiracetam – 500 mg PO BID
Class: Antiepileptic
Purpose: Seizure prophylaxis
Side Effects: Irritability, fatigueBaclofen – 5 mg PO TID
Class: Antispasticity agent
Purpose: Reduces muscle tone
Side Effects: Weakness, drowsinessClonazepam – 0.5 mg PO HS
Class: Benzodiazepine
Purpose: Controls myoclonic jerks
Side Effects: Sedation, dependencePiracetam – 1.2 g PO TID
Class: Nootropic
Purpose: Enhances mitochondrial function
Side Effects: Nervousness, weight gainCiticoline – 500 mg PO BID
Class: Neuroprotectant
Purpose: Stabilizes cell membranes
Side Effects: GI discomfortOmega-3 Fatty Acids – 1 g PO BID
Class: Nutraceutical
Purpose: Anti-inflammatory, supports remyelination
Side Effects: Fishy aftertasteZinc Sulfate – 220 mg PO daily
Class: Trace element
Purpose: Cofactor for antioxidant enzymes
Side Effects: NauseaMagnesium Sulfate – 1 g IV daily
Class: Electrolyte
Purpose: NMDA receptor modulation
Side Effects: FlushingVitamin E – 400 IU PO daily
Class: Antioxidant
Purpose: Protects myelin lipids
Side Effects: Bleeding risk at high dosesCoenzyme Q₁₀ – 100 mg PO daily
Class: Mitochondrial cofactor
Purpose: Improves cellular energy metabolism
Side Effects: GI upsetL-Carnitine – 500 mg PO TID
Class: Mitochondrial transport agent
Purpose: Facilitates fatty acid oxidation
Side Effects: Fishy odor
Dietary Molecular Supplements
Alpha-Lipoic Acid – 300 mg PO BID
Function: Antioxidant, regenerates vitamin C/E
Mechanism: Chelates metals, scavenges free radicalsCurcumin (Turmeric Extract) – 500 mg PO TID
Function: Anti-inflammatory
Mechanism: Inhibits NF-κB pathwayResveratrol – 150 mg PO daily
Function: Sirtuin activator
Mechanism: Promotes mitochondrial biogenesisLuteolin – 100 mg PO daily
Function: Mast cell stabilizer
Mechanism: Inhibits histamine releasePhosphatidylserine – 100 mg PO TID
Function: Membrane stabilizer
Mechanism: Supports synaptic functionAcetyl-L-Carnitine – 500 mg PO BID
Function: Neurotransmitter precursor
Mechanism: Increases acetylcholine synthesisNicotinamide Riboside – 250 mg PO daily
Function: NAD⁺ precursor
Mechanism: Enhances cellular repairSulforaphane – 30 mg PO daily
Function: Phase II detox inducer
Mechanism: Activates Nrf2 antioxidant pathwayEGCG (Green Tea Extract) – 200 mg PO daily
Function: Neuroprotectant
Mechanism: Inhibits glutamate excitotoxicityGamma-Aminobutyric Acid (GABA) – 250 mg PO HS
Function: Inhibitory neurotransmitter
Mechanism: Binds GABAₐ receptors
Regenerative, Viscosupplementation & Stem-Cell Drugs
Zoledronic Acid (Bisphosphonate) – 5 mg IV annually
Function: Inhibits bone resorption
Mechanism: Induces osteoclast apoptosisDenosumab – 60 mg SC every 6 months
Function: RANKL inhibitor
Mechanism: Prevents osteoclast maturationHyaluronic Acid Injection – 2 mL IA weekly × 3
Function: Viscosupplement
Mechanism: Restores synovial fluid viscosityPlatelet-Rich Plasma (PRP) – 3 mL IA × 3 monthly
Function: Growth factor concentrate
Mechanism: Stimulates local regenerationMesenchymal Stem Cell (MSC) Suspension – 10⁶ cells IA
Function: Cellular therapy
Mechanism: Differentiates into neural/glial cellsErythropoietin – 10,000 IU IV weekly × 8
Function: Neurotrophic factor
Mechanism: Activates JAK2/STAT5 pathwayGranulocyte Colony-Stimulating Factor (G-CSF) – 5 µg/kg SC daily × 5
Function: Stem cell mobilizer
Mechanism: Releases progenitors from marrowAutologous Schwann Cell Implant – Site-specific graft
Function: Myelin restoration
Mechanism: Promotes remyelinationUmbilical Cord Blood Cells – 10⁷ cells IV
Function: Neuroregeneration
Mechanism: Secretes neurotrophic factorsRecombinant Human IGF-1 – 0.05 mg/kg SC daily
Function: Growth factor
Mechanism: Stimulates neuron survival
Surgical Procedures
Corpus Callosotomy
Procedure: Partial severing of callosal fibers
Benefit: Reduces interhemispheric seizure spreadVentriculoperitoneal Shunt
Procedure: Diverts CSF to reduce intracranial pressure
Benefit: Alleviates edemaDecompressive Craniectomy
Procedure: Bone flap removal to allow brain expansion
Benefit: Prevents herniationEndoscopic Third Ventriculostomy
Procedure: Creates CSF outflow channel
Benefit: Reduces hydrocephalusFibrin Glue Injection
Procedure: Targets necrotic areas to seal microbleeds
Benefit: Stabilizes tissueIntracerebral Biopsy
Procedure: Tissue sampling for diagnosis
Benefit: Guides targeted therapyCorticectomy
Procedure: Removal of gliotic cortex
Benefit: Reduces seizure fociStereotactic Radiosurgery
Procedure: Focused radiation on lesions
Benefit: Minimally invasive lesion controlStem-Cell-Seeded Scaffold Implant
Procedure: Biodegradable matrix with MSCs placed in corpus callosum
Benefit: Structural regenerationNeuroendoscopic Debridement
Procedure: Endoscope-guided removal of necrotic tissue
Benefit: Minimally invasive clearance
Prevention Strategies
Abstinence from Alcohol
Balanced Diet Rich in B₁, B₉, B₁₂
Regular Thiamine Supplementation in High-Risk Individuals
Early Screening in Chronic Alcoholics
Routine MRI for Neurological Symptoms
Management of Liver Disease to Prevent Malabsorption
Education on Signs of Wernicke’s Encephalopathy
Avoidance of Rapid IV Glucose without Thiamine
Vaccination against Hepatitis Viruses
Support Groups to Encourage Recovery
8. When to See a Doctor
Seek medical attention if you experience confusion, unexplained behavioral changes, difficulty speaking or walking, severe headache, seizures, or visual disturbances—especially if you have a history of heavy alcohol use.
Do” and “Avoid” Guidelines
Do:
Eat thiamine-rich foods (whole grains, legumes)
Stay hydrated with electrolyte solutions
Follow prescribed vitamin regimens
Attend regular neurology follow-ups
Engage in supervised rehabilitation
Avoid:
Binge drinking or heavy alcohol use
Skipping vitamin injections or oral doses
Rapid fluid/electrolyte shifts without medical guidance
High-risk activities without assistive devices
Ignoring early cognitive or gait changes
Frequently Asked Questions
What causes Marchiafava–Bignami Disease?
Chronic alcoholism combined with B-vitamin deficiencies leads to toxic demyelination of the corpus callosum.Can MBD be reversed?
Early treatment with thiamine and corticosteroids can halt progression and even partially reverse symptoms in mild cases.How is MBD diagnosed?
MRI revealing symmetric callosal lesions, along with clinical history and lab tests for vitamin levels, confirm the diagnosis.What is the prognosis?
Acute type A has a high mortality rate, whereas type B may recover substantially with prompt treatment.Is surgery always required?
Only in cases with life-threatening edema or hydrocephalus; otherwise, conservative management is preferred.Can MBD recur?
Recurrence is rare if underlying alcohol use and nutritional deficiencies are addressed.Are there support groups?
Yes—many neurological and addiction recovery organizations offer MBD-specific or neurorehabilitation support.How long is rehabilitation?
Duration varies from weeks to months depending on severity; ongoing exercises may be needed.Are there genetic factors?
No clear genetic predisposition; lifestyle factors predominate.Can non-drinkers get MBD?
Extremely rare; isolated cases linked to malnutrition or metabolic disorders have been reported.Does MBD affect children?
Almost exclusively an adult disease due to its link to chronic alcoholism.What role do antioxidants play?
They mitigate oxidative stress in demyelinated tissues and support recovery.Is cognitive therapy beneficial?
Yes—occupational and speech therapy improve daily functioning and communication.How should families prepare?
Education on disease course, home modifications, and care strategies enhances outcomes.What research is ongoing?
Studies into neuroprotective agents (e.g., erythropoietin) and stem cell therapies show promise for future treatments.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: June 30, 2025.
